Cargando…
Targeting PDK1 for Chemosensitization of Cancer Cells
Despite the rapid development in the field of oncology, cancer remains the second cause of mortality worldwide, with the number of new cases expected to more than double in the coming years. Chemotherapy is widely used to decelerate or stop tumour development in combination with surgery or radiation...
Autores principales: | Emmanouilidi, Aikaterini, Falasca, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664079/ https://www.ncbi.nlm.nih.gov/pubmed/29064423 http://dx.doi.org/10.3390/cancers9100140 |
Ejemplares similares
-
A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth
por: Raimondi, C, et al.
Publicado: (2010) -
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
por: Casari, Ilaria, et al.
Publicado: (2019) -
The Landscape of PDK1 in Breast Cancer
por: Wang, Na, et al.
Publicado: (2022) -
A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion
por: Raimondi, Claudio, et al.
Publicado: (2016) -
Targeting the Endocannabinoidome in Pancreatic Cancer
por: Falasca, Valerio, et al.
Publicado: (2022)